Cytokinetics | CYTK - Cost Of Sales


Cytokinetics reported $160K in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 24.79M 1.43M Mar/2026
Amgen USD 1.6B 187M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Biogen USD 797.5M 302M Mar/2026
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Cytokinetics USD 160K 104.24M Mar/2026
Eisai JPY 52.02B 931M Mar/2026
Eli Lilly USD 3.58B 205M Mar/2026
Exelixis USD 19.95M 6.53M Mar/2026
Geron USD 1.69M 386K Mar/2026
Halozyme Therapeutics USD 108.75M 6.6M Mar/2026
Ionis Pharmaceuticals USD 3M 5M Mar/2026
Ligand Pharmaceuticals USD 11.37M 8.38M Mar/2026
Merck USD 2.94B 380M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Pfizer USD 4.59B 1.7B Mar/2026
Regeneron Pharmaceuticals USD 669.4M 84.8M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026